Leiner, MonoSol Deal Brings Oral Strip Technology To Private Label Market
This article was originally published in The Tan Sheet
Executive Summary
Leiner will launch at least three new OTC drug and dietary supplement products in orally dissolving strip formulations later this year under a licensing agreement with MonoSol Rx